Home | All trials

[RDF data]
Trial NCT00000191

Resource URI: http://static.linkedct.org/resource/trials/NCT00000191
PropertyValue
linkedct:brief_title Carbamazepine Treatment for Cocaine Dependence - 5
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/8837>
linkedct:condition <http://static.linkedct.org/resource/condition/2992>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 51 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000191
rdfs:label Trial NCT00000191
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/160264>
linkedct:nct_id NCT00000191
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Carbamazepine Treatment for Cocaine Dependence
linkedct:org_study_id NIDA-00144-5
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/24916>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000191>
linkedct:phase Phase 2
linkedct:secondary_id K20-00144-5
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
rdf:type linkedct:trials
linkedct:verification_date December 2002